|
|
|
Volumn 3, Issue 49-60, 2000, Pages 49-60
|
|
The cost effectiveness of eformoterol via Turbohaler® and salmeterol via pressurised metered dose inhaler and metered dose powder inhaler in mild to moderate asthma
a
|
|
Author keywords
Accuhaler; Asthma; Cost effectiveness; Eformoterol; pMDI; Salmeterol; Turbohaler
|
|
Indexed keywords
BECLOMETASONE;
BECLOMETASONE DIPROPIONATE;
BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
FLUTICASONE;
FORMOTEROL;
SALBUTAMOL;
SALMETEROL;
SALMETEROL XINAFOATE;
STEROID;
TERBUTALINE;
ADULT;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COST EFFECTIVENESS ANALYSIS;
EMERGENCY WARD;
FEMALE;
HEALTH CARE COST;
HEALTH ECONOMICS;
HOSPITALIZATION;
HUMAN;
IRELAND;
MAJOR CLINICAL STUDY;
MALE;
METERED DOSE INHALER;
POWDER INHALER;
PRIMARY MEDICAL CARE;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RESPIRATORY TRACT DISEASE;
STATISTICAL ANALYSIS;
SYMPTOM;
UNITED KINGDOM;
|
|
EID: 0033870832
PISSN: 13696998
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (5)
|
|
References (25)
|
